Like other platinum-based drugs, satraplatin works by interfering with the DNA replication process in cancer cells. It forms cross-links in DNA strands, preventing the cells from dividing and ultimately leading to cell death. This mechanism targets rapidly dividing cancer cells while sparing most normal cells, thereby reducing the tumor size and inhibiting cancer progression.
